GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beleave Inc (OTCPK:BLEVF) » Definitions » EBITDA Margin %

BLEVF (Beleave) EBITDA Margin % : -545.17% (As of Dec. 2019)


View and export this data going back to 2016. Start your Free Trial

What is Beleave EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Beleave's EBITDA for the three months ended in Dec. 2019 was $-1.58 Mil. Beleave's Revenue for the three months ended in Dec. 2019 was $0.29 Mil. Therefore, Beleave's EBITDA margin for the quarter that ended in Dec. 2019 was -545.17%.


Beleave EBITDA Margin % Historical Data

The historical data trend for Beleave's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beleave EBITDA Margin % Chart

Beleave Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -1,296.00

Beleave Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -358.74 -1,301.54 -55.27 -253.60 -545.17

Competitive Comparison of Beleave's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Beleave's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beleave's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beleave's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Beleave's EBITDA Margin % falls into.



Beleave EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Beleave's EBITDA Margin % for the fiscal year that ended in Mar. 2019 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2019 )/Revenue (A: Mar. 2019 )
=-23.004/1.775
=-1,296.00 %

Beleave's EBITDA Margin % for the quarter that ended in Dec. 2019 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2019 )/Revenue (Q: Dec. 2019 )
=-1.581/0.29
=-545.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beleave  (OTCPK:BLEVF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Beleave EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Beleave's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beleave Business Description

Traded in Other Exchanges
N/A
Address
1653 Highway No. 6 North, Flamborough, ON, CAN, L8N 2Z7
Beleave Inc is a vertically integrated Canadian cannabis company. It operates streamlined facilities throughout Canada to cultivate high quality cannabis flower, oil and extracts with funded capacity more than 150,000 kilograms per year. Fully licensed to cultivate and sell medical and recreational cannabis, it is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. The company is currently developing new product lines as the recreational market is expected to allow for food and beverage-based cannabis products.